Literature DB >> 6172505

Specific thymus-derived (T) cell recognition of papova virus-transformed cells.

M I Greene, L L Perry, E Kinney-Thomas, T L Benjamin.   

Abstract

As a first step toward identifying papova virus-specific transplantation antigens and characterizing the immune response to these antigens, a series of congenic B10 mouse lines transformed by polyoma virus and SV40 has been obtained. B10.D2 (H-2d) mice immunized with x-irradiated polyoma-transformed B10.D2 cells (PyB10.D2) contained within their spleens a population of T cells that upon restimulation in vitro preferentially lyse 51Cr-labeled PyB10.D2 compared with other allogeneic polyoma-transformed target cells or SV40-transformed B10.D2 cells. Twenty hours after acute infection with polyoma virus, SV10.D2 cells express cell surface structures recognizable by polyoma-specific CTL. This CTL activity is therefore both polyoma specific and H-2 restricted, indicating associative recognition of H-2 molecules along with the virus-specific antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6172505

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Protection against polyoma virus-induced tumors is perforin-independent.

Authors:  Anthony M Byers; Annette Hadley; Aron E Lukacher
Journal:  Virology       Date:  2006-09-28       Impact factor: 3.616

2.  A short peptide eluted from the H-2Kb molecule of a polyomavirus-positive tumor corresponds to polyomavirus large T antigen peptide at amino acids 578 to 585 and induces polyomavirus-specific immunity.

Authors:  Z Berke; S Palmer; T Bergman; D Wester; J Svedmyr; S Linder; H Jornvall; T Dalianis
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 3.  Membrane antigens associated with infection, transformation, and tumorigenesis by polyoma virus.

Authors:  I P Witz; G Meyer
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

Review 4.  Regulation of the immune response to antigens on the malignant cell surface.

Authors:  J A Drebin; L L Perry; R Carter; M I Greene
Journal:  Springer Semin Immunopathol       Date:  1982

5.  Immunological elimination of infected cells as the candidate mechanism for tumor protection in polyomavirus-infected mice.

Authors:  J J Wirth; M M Fluck
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

Review 6.  The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Authors:  Jaclyn A Freudenberg; Qiang Wang; Makoto Katsumata; Jeffrey Drebin; Izumi Nagatomo; Mark I Greene
Journal:  Exp Mol Pathol       Date:  2009-05-18       Impact factor: 3.362

7.  Therapeutic effect of interleukin 12 on mouse haemangiosarcomas is not associated with an increased anti-tumour cytotoxic T-lymphocyte activity.

Authors:  C Vizler; A Rosato; F Calderazzo; L Quintieri; P Fruscella; R Wainstok de Calmanovici; A Mantovani; A Vecchi; P Zanovello; D Collavo
Journal:  Br J Cancer       Date:  1998-02       Impact factor: 7.640

8.  Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.

Authors:  A E Lukacher; Y Ma; J P Carroll; S R Abromson-Leeman; J C Laning; M E Dorf; T L Benjamin
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.